NAUT Stock Analysis: Buy, Sell, or Hold?
NAUT - Nautilus Biotechnolgy, Inc. Common Stock
$2.40
-0.11 (-4.38%)
▼
5d:
-20.53%
30d:
-20.79%
90d:
-10.78%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
NAUT is down 6.3% this week, but smart money is accumulating calls. Top strike: $2.5 2026-06-18 with 251 OI. Call ratio: 100% View Scanner →
Strength: 8.2/10
Get Alerted When NAUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NAUT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NAUT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NAUT is currently trading at $2.40, which is considered oversold relative to its 30-day fair value range of $2.67 to $3.10.
Technical Outlook: Technically, NAUT is showing support break momentum. The price is currently testing key support at $2.42. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: NAUT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.00 (+59.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NAUT is showing support break momentum. The price is currently testing key support at $2.42. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: NAUT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.00 (+59.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.67 -
$3.10
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding NAUT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 59.4% below Wall St target ($4.00)
- CAUTION: 5-day price weakness (-20.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.67 -
$3.10
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.43
Resistance Level
$3.16
Current Trend
Support Break
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.83
Wall Street Target
$4.00
(+59.4%)
Share & Embed Analysis
Last updated: May 18, 2026 12:16 PM ET
Data refreshes hourly during market hours. Next update: 1:16 PM
Data refreshes hourly during market hours. Next update: 1:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAUT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Sujal M Patel
BUY
25000 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 63 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 50 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$293 | 60 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 42 HOLD |
Advanced NAUT Option Strategies
Professional options setups generated by AI based on today's NAUT price and gamma walls.
